How Often Do You Get B12 Injections for Weight Loss — and Do They Actually Work?

Vitamin B12 injections are licensed in the UK to treat B12 deficiency, not weight loss, there is no approved dosing schedule for the latter.
GLP-1 medicines such as tirzepatide (Mounjaro) and semaglutide (Wegovy) are the weekly injections with a UK licence for weight management.
B12 injections are sometimes bundled with weight-loss programmes at private clinics, but the supporting evidence for weight-specific benefit is lacking in people with normal B12 levels.
If you are considering injectable treatment for weight management, the starting point is a clinical assessment by a qualified prescriber, not a frequency schedule.

B12 injections for weight loss are usually marketed as weekly or monthly shots, but the honest answer is that there is no licensed dose or schedule for this purpose in the UK. Vitamin B12 has no proven direct effect on body weight in people who are not deficient. If you have seen B12 jabs advertised alongside GLP-1 medicines such as Mounjaro or Wegovy, it is worth understanding what each one actually does — and which ones are backed by clinical evidence for weight management. These are prescription-only medicines, and a prescriber decides what is appropriate for your situation after a proper assessment.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence actually says about injectable treatments and weight management in the UK

You have seen a clinic advertising weekly B12 jabs, here is what that actually means

Picture the scenario: you have come across a weight-loss clinic, an Instagram advert, or a friend's recommendation for B12 injections offered weekly or fortnightly, sometimes alongside other supplements. It feels plausible. B12 is involved in energy metabolism, and if your levels are low you can feel genuinely fatigued and sluggish. The problem is that fatigue caused by deficiency and excess body weight are different problems with different solutions.

In the UK, intramuscular B12 injections (hydroxocobalamin) are licensed to treat confirmed B12 deficiency, conditions like pernicious anaemia or absorption problems after certain gut surgeries. The NHS schedule for that purpose is typically every two to three months once levels are stable, or more frequently at the start of treatment. None of that applies to weight loss. The NHS's guidance on healthy weight does not include B12 supplementation in its evidence-based recommendations for weight management.

Why do clinics offer it, then? Partly habit, partly the placebo effect of an injection feeling like medical treatment, partly because some people do have low-normal B12 levels that affect their energy and mood. Correcting a genuine deficiency might help you feel better during a weight-loss programme, but the injection is not doing the weight-loss work. If you are in that situation and feeling frustrated that results are slow, it is worth naming that: the B12 shot is unlikely to be the lever that changes things.

The weekly injections that do carry a UK licence for weight loss

The weekly injectable treatments with a genuine UK regulatory licence for weight management are a different category entirely. Tirzepatide, sold as Mounjaro, and semaglutide, sold as Wegovy, are both given as once-weekly subcutaneous injections. Their mechanism is pharmacological: tirzepatide activates two gut-hormone receptors (GIP and GLP-1), slowing how quickly the stomach empties and reducing appetite at the brain. Semaglutide works on the GLP-1 receptor alone but with a similarly meaningful clinical effect.

The trial evidence is substantial. In the SURMOUNT-1 trial, tirzepatide produced an average body-weight reduction of around 20 to 21 percent over 72 weeks at the highest dose. That data, published in the New England Journal of Medicine, involved thousands of adults with obesity. Semaglutide showed around 15 percent average loss in the STEP 1 trial at 68 weeks. These are outcomes in clinical trials with proper controls, not testimonials. Neither B12 nor any other vitamin injection comes close to this evidence base for weight reduction. You can read more about how licensed weight-loss injections work if you want a fuller picture of the clinical landscape.

Both medicines are Black Triangle (▼) products under additional MHRA monitoring and are prescription-only. A prescriber sets the schedule, treatment typically starts at a low dose and is titrated over several weeks. If you are wondering how often you inject weight loss injections and how that schedule is structured across the titration period, that is covered in detail on its own page. Telling a reader what frequency they personally should use is not something any content page should do; that conversation belongs with the clinician reviewing your case.

How injection frequency differs between B12 and licensed GLP-1 medicines

If frequency is what you are trying to plan around, here is the practical contrast. B12 injections for confirmed deficiency: typically every two to three months once stable, given intramuscularly (usually into the muscle of the upper arm or buttock) at a GP practice or clinic. GLP-1 medicines for weight management: once weekly, self-administered subcutaneously (under the skin of the abdomen, thigh, or upper arm) at home. The injection technique is straightforward, and most people are comfortable with it after the first couple of uses.

If you are thinking through the practicalities of a GLP-1 treatment plan, our page on how often you use weight loss injections explains how the licensed weekly schedule works and what to expect across the titration period. Missing a dose or adjusting timing is something to discuss with your prescriber and is covered in the Patient Information Leaflet. Side effects with GLP-1 medicines are mostly gastrointestinal (nausea, loose stools, reflux) and tend to settle after the initial weeks or after a dose increase. That pattern is detailed on the NHS tirzepatide medicines page.

Storage matters too: GLP-1 pens are refrigerated. B12 ampoules have their own storage requirements. The leaflet that comes with any medicine covers this; never rely on a webpage for the exact storage window. People also sometimes ask how often you take weight loss injections when they are thinking through the practical side of injectable treatment, and that page covers what the pen looks like and how it is used, though a prescriber can walk you through it in person. If you are curious about the practical side of injectable weight-loss treatment (what the pen looks like, how it is used) it is easier to get that from a prescriber who can walk you through it.

What to do if you genuinely want clinical support for weight management

Searching for B12 injection schedules often means the person asking is already motivated to do something, but is not sure what the right tool is. That is a reasonable position to be in, the market is noisy and the marketing is rarely honest about what the evidence actually supports.

If your BMI is 30 or above, or 27 or above with a weight-related condition such as high blood pressure, high cholesterol, or obstructive sleep apnoea, you may be eligible for a licensed GLP-1 medicine through a private prescriber. At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber. There is no algorithm reading your answers; a real clinician assesses whether treatment is appropriate for you. You can explore the options on our weight-loss treatments page, which is also the starting point for a free consultation if you decide you want one.

If you are on a GLP-1 medicine and a low B12 level comes up in blood tests (which can happen, particularly with longer-term use) that is worth discussing with your prescriber separately. It is a different clinical question from the weight-management treatment itself. Our FAQs cover a range of practical questions, or you can get in touch directly. Worth knowing before you book anything.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions